C-REV Retains High Infectivity Regardless of the Expression Levels of cGAS and STING in Cultured Pancreatic Cancer Cells

Oncolytic virus (OV) therapy is widely considered as a major breakthrough in anti-cancer treatments. In our previous study, the efficacy and safety of using C-REV for anti-cancer therapy in patients during stage I clinical trial was reported. The stimulator of interferon genes (STING)–TBK1–IRF3–IFN...

Descripción completa

Detalles Bibliográficos
Autores principales: Morimoto, Daishi, Matsumura, Shigeru, Bustos-Villalobos, Itzel, Sibal, Patricia Angela, Ichinose, Toru, Naoe, Yoshinori, Eissa, Ibrahim Ragab, Abdelmoneim, Mohamed, Mukoyama, Nobuaki, Miyajima, Noriyuki, Tanaka, Maki, Kodera, Yasuhiro, Kasuya, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232185/
https://www.ncbi.nlm.nih.gov/pubmed/34203706
http://dx.doi.org/10.3390/cells10061502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232185/
https://www.ncbi.nlm.nih.gov/pubmed/34203706
http://dx.doi.org/10.3390/cells10061502

Ejemplares similares